INTRAVITREAL RANIBIZUMAB TREATMENT FOR ADVANCED FAMILIAL EXUDATIVE VITREORETINOPATHY WITH HIGH VASCULAR ACTIVITY

PURPOSE: To determine the efficacy of intravitreal ranibizumab (IVR) treatment for advanced familial exudative vitreoretinopathy with high vascular activity. METHODS: The retrospective interventional case series included 28 eyes (20 patients) that had IVR in combination or not with other treatment,...

Descripción completa

Detalles Bibliográficos
Autores principales: Lyu, Jiao, Zhang, Qi, Xu, Yu, Zhang, Xiang, Fei, Ping, Zhao, Peiquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Retina 2021
Materias:
Original Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8384247/
https://www.ncbi.nlm.nih.gov/pubmed/34432746
http://dx.doi.org/10.1097/IAE.0000000000003122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8384247/
https://www.ncbi.nlm.nih.gov/pubmed/34432746
http://dx.doi.org/10.1097/IAE.0000000000003122

Ejemplares similares